-
EP3873436
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3873436
| EP3873436 - ORALLY ADMINISTRABLE CANNABINOIDS-CONTAINING COMPOSITIONS AND METHODS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.05.2022 Database last updated on 02.11.2024 | |
| Former | Request for examination was made Status updated on 06.08.2021 | ||
| Former | The international publication has been made Status updated on 09.05.2020 | ||
| Former | unknown Status updated on 10.12.2019 | Most recent event Tooltip | 13.05.2022 | Application deemed to be withdrawn | published on 15.06.2022 [2022/24] | Applicant(s) | For all designated states Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Hi-Tech Park Edmond J. Safra Campus Givat Ram P.O. Box 39135 9139002 Jerusalem / IL | [2021/36] | Inventor(s) | 01 /
TOUITOU, Elka 11/67 Derech Ramataim 4532311 Hod Hasharon / IL | 02 /
NATSHEH, Hiba 7 Nuseibeh St. 9701627 Jerusalem / IL | [2021/36] | Representative(s) | Russell, Tim Venner Shipley LLP 200 Aldersgate London EC1A 4HD / GB | [2021/36] | Application number, filing date | 19813165.8 | 31.10.2019 | [2021/36] | WO2019IL51180 | Priority number, date | US201862755483P | 04.11.2018 Original published format: US 201862755483 P | [2021/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020089905 | Date: | 07.05.2020 | Language: | EN | [2020/19] | Type: | A1 Application with search report | No.: | EP3873436 | Date: | 08.09.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.05.2020 takes the place of the publication of the European patent application. | [2021/36] | Search report(s) | International search report - published on: | EP | 07.05.2020 | Classification | IPC: | A61K9/08, A61K9/48, A61K31/05, A61K31/135, A61K31/167, A61K31/192, A61K31/352, A61K31/355, A61K31/4178, A61K31/4196, A61K31/422, A61K31/439, A61K31/5513, A61K47/10, A61K47/24, A61K47/44, A61P25/04 | [2021/36] | CPC: |
A61K9/08 (EP);
A61K31/05 (EP,US);
A61K31/192 (EP);
A61K31/352 (EP,US);
A61K31/353 (EP);
A61K47/10 (EP);
A61K47/24 (EP,US);
A61K47/44 (EP);
A61K9/0053 (US);
A61K9/4808 (EP);
A61K9/4858 (US);
A61K9/4866 (US);
A61P25/04 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/36] | Title | German: | ORAL VERABREICHBARE CANNABINOIDE ENTHALTENDE ZUSAMMENSETZUNGEN UND VERFAHREN | [2021/36] | English: | ORALLY ADMINISTRABLE CANNABINOIDS-CONTAINING COMPOSITIONS AND METHODS | [2021/36] | French: | COMPOSITIONS CONTENANT DES CANNABINOÏDES ADMINISTRABLES PAR VOIE ORALE ET PROCÉDÉS | [2021/36] | Entry into regional phase | 21.05.2021 | National basic fee paid | 21.05.2021 | Designation fee(s) paid | 21.05.2021 | Examination fee paid | Examination procedure | 21.05.2021 | Examination requested [2021/36] | 21.05.2021 | Date on which the examining division has become responsible | 04.01.2022 | Application deemed to be withdrawn, date of legal effect [2022/24] | 27.01.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2022/24] | 27.01.2022 | Despatch of communication of loss of particular rights: Claims {1} | Fees paid | Renewal fee | 25.10.2021 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO2016144376 (NANOSPHERE HEALTH SCIENCES LLC [US]) [X] 1-8,12-19 * example 1 *; | [XD]WO2017098502 (YISSUM RES DEV CO [IL]) [XD] 1-19 * examples 2,3 *; | [XP]WO2019106652 (YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD [IL]) [XP] 1-19 * the whole document * | [A] - LODZKI M ET AL, "Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, (20031212), vol. 93, no. 3, doi:10.1016/J.JCONREL.2003.09.001, ISSN 0168-3659, pages 377 - 387, XP004476726 [A] 1-19 * abstract * * passages relating to figure 2; page 383 * DOI: http://dx.doi.org/10.1016/j.jconrel.2003.09.001 | by applicant | WO2017098502 | US3968125 | US4206225 | US4232018 | US4260764 | US4235913 | US4243674 | US4263438 | US4270005 | US4283569 | US4876276 | US5521215 | US6162829 | US4371720 | US4663474 | US5847128 | - GAONI YMECHOULAM R, Tetrahedron Letters, (19850000), vol. 26, no. 8, pages 1083 - 1086 | - PETILKA et al., Helv. Chim. Acta, (19690000), vol. 52, page 1102 | - J. Am. Chem. Soc., (19650000), vol. 87, no. 327, page 3 | - NOVAK et al., Tetrahedron Letters, (19820000), vol. 23, page 253 | - JESSE ATESKEALEXANDER DEITERS, Org. Lett., (20080000), vol. 10, no. 11, pages 2195 - 2198 | - SIEGEL et al., J. Org. Chem., (19890000), vol. 54, page 5428 |